Detalhe da pesquisa
1.
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes.
Am J Transplant
; 21(4): 1477-1492, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627352
2.
Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
Am J Kidney Dis
; 70(6): 762-769, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801121
3.
The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysisâ©.
Clin Nephrol
; 87 (2017)(3): 124-133, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28128726
4.
Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.
J Am Soc Nephrol
; 27(7): 2109-21, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538631
5.
Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.
J Am Soc Nephrol
; 24(11): 1820-9, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23907509
6.
Pyridorin in type 2 diabetic nephropathy.
J Am Soc Nephrol
; 23(1): 131-6, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22034637
7.
Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study.
Diabetes Care
; 2022 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250905
8.
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.
Am J Kidney Dis
; 58(5): 729-36, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21872376
9.
Physician access and early nephrology care in elderly patients with end-stage renal disease.
Kidney Int
; 74(12): 1596-602, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18509317
10.
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
Nephrol Dial Transplant
; 23(6): 1946-54, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18089623
11.
Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia.
Diabetes Care
; 41(5): 1001-1008, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29563196
12.
Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.
Hepatol Commun
; 1(5): 460-468, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29404473
13.
B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
Transplantation
; 101(1): 182-190, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26910333
14.
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Am Heart J
; 152(3): 448.e1-7, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16923411
15.
The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Am J Kidney Dis
; 48(4): 571-9, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16997053
16.
Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches.
Health Serv Res
; 41(6): 2267-89, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17116120
17.
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia.
Diabetes Care
; 39(7): 1230-40, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27208344
18.
National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities.
Diabetes
; 65(11): 3418-3428, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465220
19.
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy.
Am J Kidney Dis
; 45(2): 281-7, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15685505
20.
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
Ann Intern Med
; 138(7): 542-9, 2003 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12667024